Lanean...

Optimal Bronchodilation for COPD Patients: Are All Long-Acting β(2)-Agonist/Long-Acting Muscarinic Antagonists the Same?

Bronchodilators provide improvements in lung function and reductions in symptoms and exacerbations, and are the mainstay of pharmacological management of chronic obstructive pulmonary disease (COPD). The Global Initiative for Chronic Obstructive Lung Disease strategy recommends the use of a combinat...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Tuberc Respir Dis (Seoul)
Egile Nagusiak: Miravitlles, Marc, Baek, Seungjae, Vithlani, Vatsal, Lad, Rahul
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: The Korean Academy of Tuberculosis and Respiratory Diseases 2018
Gaiak:
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6030660/
https://ncbi.nlm.nih.gov/pubmed/29926556
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4046/trd.2018.0040
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!